Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: The missing link with multiple sclerosis?

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Mameli, Giuseppe ^a   Madeddu, Giordano ^a   Mei, Alessandra ^a   Uleri, Elena ^a   Poddighe, Luciana ^a   Delogu, Lucia G ^a   Maida, Ivana ^a   Babudieri, Sergio ^a   Serra, Caterina ^a   Manetti, Roberto ^a   Mura, Maria S ^a   Dolei, Antonina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; ENDOGENOUS RETROVIRUSES; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; LEUKOCYTES, MONONUCLEAR; MALE; MULTIPLE SCLEROSIS; RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY; YOUNG ADULT;

EID: 84891485523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078474     Document Type: Article

References (60)

1. McQualter JL, Bernard CC (2007) Multiple sclerosis: a battle between destruction and repair. J Neurochem 100: 295-306. (Pubitemid 46010991)
2. Kakalacheva K, Münz C, Lünemann JD (2011) Viral triggers of multiple sclerosis. Biochim Biophys Acta 1812: 132-140.
3. Christensen T (2010) HERVs in neuropathogenesis. J Neuroimmune Pharmacol 5: 326-335.
4. Cusick MF, Libbey JE, Fujinami RS (2013) Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol 25: 496-501.
5. Ascherio A, Munger KL (2010) Epstein-Barr virus infection and multiple sclerosis: a review J Neuroimmune Pharmacol 5: 271-277.
6. Almohmeed YH, Avenell A, Aucott L, Vickers MA (2013) Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis. PLoS One 8 :e61110.
7. Santiago O, Gutierrez J, Sorlozano A, De Dios Luna J, Villegas E, et al. (2010) Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur. J Clin Microbiol Infect Dis 29: 857-866.
8. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, et al. (2010) An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 5: e12496.
9. Dolei A (2006) Endogenous retroviruses and human disease. Exp Rev Clin Immunol 2: 149-167.
10. Dolei A, Perron H (2009) The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. J Neurovirol 15: 4-13.
11. Perron H, Lang A (2010) The Human Endogenous Retrovirus Link between Genes and Environment in Multiple Sclerosis and in Multifactorial Diseases Associating Neuroinflammation. Clinic Rev Allerg Immunol 39: 51-61.
12. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C (2011) Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochem Biophys Acta 2: 162-176.
13. Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, et al. (2012) Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One 7: e44991.
14. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, et al. (1997) The Collaborative Research Group on Multiple Sclerosis: Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 94: 7583-7588. (Pubitemid 27345359)
15. Antony JM, Van Marle G, Opii W, Butterfield DA, Mallet F, et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 7: 1088-1095. (Pubitemid 41184449)
16. Mi S, Lee X, Li X, Veldman GM, Finnerty H, et al. (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403: 785-789. (Pubitemid 30111841)
17. Firouzi R, Rolland A, Michel M, Jouvin-Marche E, Hauw JJ, et al. (2003) Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J Neurovirol 9: 79-93. (Pubitemid 36372548)
18. Mameli G, Astone V, Arru G, Marconi S, Lovato L, et al (2007) Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J Gen Virol 88: 264-274. (Pubitemid 46085138)
19. Bhat RK, Ellestad KK, Wheatley BM, Warren R, Holt RA, et al. (2001) Age- and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression. PLoS One 6: e19176.
20. Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, et al. (2012) Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler 18: 1721-1736.
21. Perron H, Lazarini F, Ruprecht K, Pechoux-Longin C, Seilhean D, et al. (2005) Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol 11: 23-33. (Pubitemid 40458368)
22. Arru G, Mameli G, Astone V, Serra C, Huang YM, et al. (2007) Multiple sclerosis and HERV-W/MSRV: a multicentric study. Int J Biomed Sci 3: 292-297.
23. Dolei A, Serra C, Mameli G, Pugliatti M, Sechi S, et al. (2002) Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58: 471-473. (Pubitemid 34150928)
24. Sotgiu S, Serra C, Mameli G, Pugliatti M, Rosati G, et al.(2002) Multiple sclerosis (MS)-associated retrovirus and MS prognosis: an observational study. Neurology 59: 1071-1073.
25. Sotgiu S, Arru G, Mameli G, Serra C, Pugliatti M, et al. (2006) MSRV in early multiple sclerosis: a six-year follow-up of a Sardinian cohort. Mult Scler 12: 698-703. (Pubitemid 46111761)
26. Sotgiu S, Mameli G, Serra C, Zarbo IR, Arru G, et al. (2010) Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult Scler 16: 1248-1251.
27. Mameli G, Serra C, Astone V, Castellazzi M, Poddighe L, et al. (2008) Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol 14: 73-77. (Pubitemid 351314975)
28. Sotgiu S, Arru G, Söderström M, Mameli G, Serra C, et al. (2006) MSRV and optic neuritis. Mult Scler 12: 357-359.
29. Petersen T, Møller-Larsen A, Thiel S, Brudek T, Hansen TK et al. (2009) Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis. J Neuroimmunol 215: 108-116.
30. Pakpoor J, Giovannoni G, Ramagopalan SV (2013) Epstein-Barr virus and multiple sclerosis: association or causation? Expert Rev Neurother 13: 287-297.
31. Tselis A (2012) Epstein-Barr virus cause of multiple sclerosis. Curr Opin Rheumatol 24: 424-428.
32. Ascherio A and Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 61: 288-299. (Pubitemid 46676728)
33. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol 67: 824-830.
34. Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, et al. (2013) The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Mult Scler 19: 162-166.
35. Munger K, Levin L, O'Reilly E, Falk K, Ascherio A (2011) Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 17: 1185-1193.
36. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D (2004) Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health 58: 1032-1035. (Pubitemid 39564205)
37. Lucas RM, Hughes AM, Lay ML, Ponsonby AL, Dwyer DE, et al. (2011) Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatry 82: 1142-1148.
38. Nielsen TR, Rostgaard K, Askling J, Steffensen R, Oturai A, et al. (2009) Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler 15: 431-436.
39. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, et al. (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 9: 773-781. (Pubitemid 47238663)
40. Lünemann JD, Tintoré M, Messmer B, Strowig T, Rovira A, et al. (2010) Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 67: 159-169.
41. Owens GP, Bennett JL (2012) Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis. Mult Scler 18: 1204-1208.
42. Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM, NeuroproMiSe EBV Working Group (2011) Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 134: 2772-2786.
43. Borkosky SS, Whitley C, Kopp-Schneider A, zur Hausen H, de Villiers EM (2012) Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. PLoS One 7: e32160.
44. Komijani M, Bouzari M, Etemadifar M, Zarkesh-Esfahani H, Shaykh-Baygloo N, et al. (2011) Torque teno mini virus infection and multiple sclerosis. Int J Neurosci 121: 437-441.
45. Mameli G, Poddighe L, Astone V, Delogu G, Arru G, et al. (2009) Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. J Virol Methods 161: 98-106.
46. Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, et al. (2013) Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 207: 80-88.
47. Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, et al. (2009) B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology 6: 104.
48. Kim DY, Hong GU, Ro JY (2011) Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation 8: 25.
49. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, et al. (2003) In vitro modulation of the multiple sclerosis (MS)-associated retrovirus (MSRV) by cytokines: implications for MS pathogenesis. J NeuroVirol 9: 637-643. (Pubitemid 37536719)
50. Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8: 1254-1266.
51. Rawji KS, Yong VW (2013) The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin Dev Immunol. 2013: 948976.
52. Pfeiffer F, Schäfer J, Lyck R, Makrides V, Brunner S, et al. (2011) Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol 122: 601-614.
53. Disanto G, Morahan JM, Barnett MH, Giovannoni G, Ramagopalan SV (2012) The evidence for a role of B cells in multiple sclerosis. Neurology 78: 823-832.
54. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E (2013) Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One 8: e66308.
55. Chung BK, Tsai K, Allan LL, Zheng DJ, Nie JC, et al. (2013) Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood Aug 23. [Epub ahead of print]
56. Meier UC, Giovannoni G, Tzartos JS, Khan G (2012) Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system? Clin Exp Immunol 167: 1-6.
57. Coppotelli G, Mughal N, Callegari S, Sompallae R, Caja L, et al. (2013) The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins. Nucleic Acids Res 41: 2950-2962.
58. Wood VH, O'Neil JD, Wei W, Stewart SE, Dawson CW, et al. (2007) Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 26: 4135-4147. (Pubitemid 46920177)
59. Dresang LR, Vereide DT, Sugden B (2009) Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. J Virol 83: 2930-2940.
60. DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, et al. (2006) Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63: 839-844. (Pubitemid 43882291)